Guanfacine and Guanabenz are primarily agonists at which receptors?

Prepare for the Manor Preboards Test with module 4 quiz. Utilize flashcards and interactive questions, each designed with helpful explanations. Get ready for your success!

Multiple Choice

Guanfacine and Guanabenz are primarily agonists at which receptors?

Explanation:
Guanfacine and guanabenz act mainly as agonists of the alpha-2 adrenergic receptors, with the key action occurring at presynaptic sites in the central nervous system. When these presynaptic alpha-2 receptors are stimulated on norepinephrine-releasing neurons, they reduce the release of norepinephrine. That dampens sympathetic outflow, producing calming, antihypertensive effects. They are not acting on M1 muscarinic receptors, nicotinic (NN) receptors, or alpha-1 receptors. The presynaptic location is crucial because the primary therapeutic effect comes from inhibiting norepinephrine release rather than activating other receptor types that produce different responses.

Guanfacine and guanabenz act mainly as agonists of the alpha-2 adrenergic receptors, with the key action occurring at presynaptic sites in the central nervous system. When these presynaptic alpha-2 receptors are stimulated on norepinephrine-releasing neurons, they reduce the release of norepinephrine. That dampens sympathetic outflow, producing calming, antihypertensive effects. They are not acting on M1 muscarinic receptors, nicotinic (NN) receptors, or alpha-1 receptors. The presynaptic location is crucial because the primary therapeutic effect comes from inhibiting norepinephrine release rather than activating other receptor types that produce different responses.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy